Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Peter Sand

Urogynecology and Reconstructive Pelvic Surgery Skokie, IL Medical Doctor

NPI 1700984408 CMS profile 697002

9650 Gross Point Rd # 3900, Skokie, IL 60076

Open in the dashboard

General payments

$184,873

105 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$762 paid to institutions, not to them · program year 2019

Through program year 2024, Peter Sand of Skokie, IL is reported in the CMS Open Payments database as having received $184,873 across 105 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $762 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Urogynecology and Reconstructive Pelvic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $6,825 2
2023 General $99,760 5
2022 General $21,210 31
2021 General $20,354 19
2020 General $16,564 15
2019 General $20,161 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Sand
  • Urogynecology and Reconstructive Pelvic Surgery median
  • Middle half of Urogynecology and Reconstructive Pelvic Surgery
  • National median

In program year 2025, general payments to Peter Sand were reported at $0. Among 802 Urogynecology and Reconstructive Pelvic Surgery profiles paid that year, the median was $412 and the middle half received between $133 and $1,300.

Show as a table
Year Peter Sand Urogynecology and Reconstructive Pelvic Surgery median Middle half National median
2019 $20,161 $358 $132–$1,270 $163
2020 $16,564 $198 $86–$642 $114
2021 $20,354 $361 $118–$1,182 $132
2022 $21,210 $410 $128–$1,175 $149
2023 $99,760 $434 $152–$1,344 $160
2024 $6,825 $494 $193–$1,331 $164
2025 $0 $412 $133–$1,300 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Valencia Technologies Corporation $94,337 1 payment
  2. Urovant Sciences Inc $26,915 37 payments
  3. Allergan Inc. $25,488 31 payments
  4. Sumitomo Pharma America, Inc. $12,248 6 payments
  5. Ferring Pharmaceuticals Inc. $7,860 13 payments
  6. AbbVie, Inc. $7,273 6 payments
  7. Antares Pharma, Inc. $4,515 2 payments
  8. Hologic, LLC $4,367 5 payments
  9. Jazz Pharmaceuticals Inc. $1,719 1 payment
  10. Laborie Medical Technologies Corp. $112 1 payment
  11. Other $42 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $119,350 9 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $55,485 30 payments
  3. Travel and Lodging $7,951 37 payments
  4. Food and Beverage $2,088 29 payments
Products named General payments · program years 2019–2024
  1. eCoin Device Kit $94,337 1 payment
  2. GEMTESA $34,798 42 payments
  3. BOTOX Urology $14,593 10 payments
  4. BOTOX Urology $12,177 18 payments
  5. NOCDURNA $7,860 13 payments
  6. BOTOX Urology $5,975 7 payments
  7. XYOSTED $4,500 1 payment
  8. SUNOSI $1,719 1 payment
  9. GENTLECATH $26 1 payment
  10. Axonics r-SNM System $16 1 payment
  11. Other $30 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

105 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Urogynecology and Reconstructive Pelvic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record